Mechanisms of Fronto-Subcortical Dysfunction: Comparing PD and OCD

The recruitment status of this study is unknown because the information has not been verified recently.
Verified November 2008 by Sheba Medical Center.
Recruitment status was  Not yet recruiting
Sponsor:
Collaborators:
University of Haifa
Israel Science Foundation
Information provided by:
Sheba Medical Center
ClinicalTrials.gov Identifier:
NCT00790634
First received: November 12, 2008
Last updated: NA
Last verified: November 2008
History: No changes posted
  Purpose

The purpose of this study is to characterize and compare irregularities in dopaminergic function in fronto-subcortical circuits, between Parkinson's Disease patients (ON and OFF medication) and patients with obsessive-compulsive disorder, by examining performance on cognitive tasks involving cognitive flexibility, decision-making, and attentional bias.


Condition
Parkinson's Disease
Obsessive-Compulsive Disorder

Study Type: Observational
Study Design: Observational Model: Case Control
Time Perspective: Prospective
Official Title: Characterizing Mechanisms of Fronto-Subcortical Dysfunction: A Comparison Between Parkinson's Disease and Obsessive-Compulsive Disorder

Resource links provided by NLM:


Further study details as provided by Sheba Medical Center:

Estimated Enrollment: 100
Study Start Date: December 2008
Estimated Study Completion Date: December 2011
Estimated Primary Completion Date: December 2011 (Final data collection date for primary outcome measure)
Groups/Cohorts
Parkinson's Disease
Patients with idiopathic Parkinson's disease
Obsessive-compulsive disorder
Individuals with a diagnosis of obsessive-compulsive disorder
OCD controls
Healthy controls, matched in age and number to obsessive-compulsive group
PD controls
Healthy controls, matched in age and number to Parkinson's disease group

  Eligibility

Ages Eligible for Study:   16 Years to 85 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population

private and hospital-based clinics, healthy volunteers

Criteria

Inclusion Criteria:

  • idiopathic PD or
  • OCD
  • for control group - age-matched to study groups

Exclusion Criteria:

  • psychotic symptoms (past or present)
  • head injury with loss of consciousness
  • other neurological conditions (excepting PD in PD group)
  • for OCD group - use of dopaminergic medications
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00790634

Contacts
Contact: Sharon Hassin, MD 97235305791 shassin@post.tau.ac.il
Contact: Sari Meril, M.Sc 972

Sponsors and Collaborators
Sheba Medical Center
University of Haifa
Israel Science Foundation
  More Information

No publications provided

Responsible Party: Dr. Sharon Hassin, principal investigator, Sheba Medical Center
ClinicalTrials.gov Identifier: NCT00790634     History of Changes
Other Study ID Numbers: SHEBA-08-5473-SH-CTIL
Study First Received: November 12, 2008
Last Updated: November 12, 2008
Health Authority: Israel: Ministry of Health

Additional relevant MeSH terms:
Obsessive-Compulsive Disorder
Parkinson Disease
Compulsive Personality Disorder
Anxiety Disorders
Mental Disorders
Parkinsonian Disorders
Basal Ganglia Diseases
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases
Movement Disorders
Neurodegenerative Diseases
Personality Disorders

ClinicalTrials.gov processed this record on August 20, 2014